Dec. 11, 2017—A fundamental advance in the quality of an optical material used to make hyperlenses makes it possible to see features on the surface of living cells in greater detail than ever before.
Nov. 30, 2017—Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.
Nov. 16, 2017—Researchers believe they can address problems stemming from heart rate, respiration and digestion by untangling which nerves control which bodily functions and then stimulating them with light.
Oct. 12, 2017—Creating a model pipeline that will assist adults on the autism spectrum find innovative jobs is the purpose of Vanderbilt University’s new Center for Autism & Innovation.
Oct. 3, 2017—Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.
Sep. 5, 2017—Inspired by Temple Grandin, Assistant Professor of Computer Science Maithilee Kunda figured out how to create artificial intelligence that emulates image-based thinking.
Aug. 25, 2017—New insights into the long-lasting effects of Fragile X syndrome on connections in the brain during early development highlight the importance of early detection and treatment.
Aug. 23, 2017—Entering its fourth year, Vanderbilt University’s Academic Strategic Plan still charts the course for the university’s efforts as it moves forward to address the complex problems facing society.
Aug. 14, 2017—A collaborative project between Vanderbilt University School of Nursing and Vanderbilt University Medical Center has received funding to pilot a project aimed at demonstrating the influence of nurse practitioners in reducing unnecessary testing.
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.